AS0369 significantly reduced NGAL levels when therapy started on days 3 and 21 but the reduction in NGAL levels did not reach statistical significance at the later stages ( Fig. 1 D).
← all excerpts
Stage-dependent effects of systemic ASBT inhibition in a cholestasis-induced cholemic nephropathy mouse model.
1
—
—